NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Oct 21 2022

· Issued by NATCO Pharma Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

This filing is a press release from NATCO Pharma Limited regarding a legal update. The company informs that FMC Corporation and FMC Singapore have appealed against a recent court judgment that allowed NATCO to launch its Chlorantraniliprole products. NATCO expresses confidence in its case and anticipates success in the appeal.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases